ALK and lung cancer: This study illustrated that STAT3 mediates treatment-induced adaptive survival of ALK-rearranged lung cancer cells through transcriptional regulation of apoptosis, identifying STAT3 as a promising therapeutic target of the combination therapy aimed at tumor eradication.